Literature DB >> 26379405

Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.

Jiang-Wei Xiao1, Zi-Lin Liu1, Peng-Cheng Ye1, Ya-Jun Luo1, Zhi-Ming Fu1, Qin Zou1, Shou-Jiang Wei1.   

Abstract

AIM: To explore a reasonable method of digestive tract reconstruction, namely, antrum-preserving double-tract reconstruction (ADTR), for patients with adenocarcinoma of the esophagogastric junction (AEG) and to assess its efficacy and safety in terms of long-term survival, complications, morbidity and mortality.
METHODS: A total of 55 cases were retrospectively collected, including 18 cases undergoing ADTR and 37 cases of Roux-en-Y reconstruction (RY) for AEG (Siewert types II and III) at North Sichuan Medical College. The cases were divided into two groups. The clinicopathological characteristics, perioperative outcomes, postoperative complications, morbidity and overall survival (OS) were compared for the two different reconstruction methods.
RESULTS: Basic characteristics including sex, age, body mass index (BMI), Siewert type, pT status, pN stage, and lymph node metastasis were similar in the two groups. No significant differences were found between the two groups in terms of perioperative outcomes (including the length of postoperative hospital stay, operating time, and intraoperative blood loss) and postoperative complications (consisting of anastomosis-related complications, wound infection, respiratory infection, pleural effusion, lymphorrhagia, and cholelithiasis). For the ADTR group, perioperative recovery indexes such as time to first flatus (P = 0.002) and time to resuming a liquid diet (P = 0.001) were faster than those for the RY group. Moreover, the incidence of reflux esophagitis was significantly decreased compared with the RY group (P = 0.048). The postoperative morbidity and mortality rates for overall postoperative complications and the rates of tumor recurrence and metastasis were not significantly different between the two groups. Survival curves plotted using the Kaplan-Meier method and compared by log-rank test demonstrated similar outcomes for the ADTR and RY groups. Multivariate analysis of significantly different factors that presented as covariates on Cox regression analysis to assess the survival and recurrence among AEG patients showed that age, gender, BMI, pleural effusion, time to resuming a liquid diet, lymphorrhagia and tumor-node-metastasis stage were important prognostic factors for OS of AEG patients, whereas the selection of surgical method between ADTR and RY was shown to be a similar prognostic factor for OS of AEG patients.
CONCLUSION: ADTR by jejunal interposition presents similar rates of tumor recurrence, metastasis and long-term survival compared with classical reconstruction with RY esophagojejunostomy; however, it offers considerably improved near-term quality of life, especially in terms of early recovery and decreased reflux esophagitis. Thus, ADTR is recommended as a worthwhile digestive tract reconstruction method for Siewert types II and III AEG.

Entities:  

Keywords:  Adenocarcinoma of the esophagogastric junction; Antrum-preserving double-tract reconstruction; Overall survival; Roux-Y reconstruction; Total gastrectomy

Mesh:

Year:  2015        PMID: 26379405      PMCID: PMC4566393          DOI: 10.3748/wjg.v21.i34.9999

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

2.  Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

Review 4.  Surgical strategies for adenocarcinoma of the esophagogastric junction.

Authors:  Marc Schiesser; Paul M Schneider
Journal:  Recent Results Cancer Res       Date:  2010

5.  Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas.

Authors:  Bryan A Whitson; Shawn S Groth; Zhongze Li; Robert A Kratzke; Michael A Maddaus
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06-13       Impact factor: 5.209

6.  Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer.

Authors:  Xiaohua Jiang; Naoki Hiki; Souya Nunobe; Tetsu Fukunaga; Koshi Kumagai; Kyoko Nohara; Hiroshi Katayama; Shigekazu Ohyama; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Surg Endosc       Date:  2010-09-16       Impact factor: 4.584

7.  Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia.

Authors:  Kenneth E L McColl; James J Going
Journal:  Gut       Date:  2010-03       Impact factor: 23.059

8.  Clinical experience of laparoscopy-assisted proximal gastrectomy with Toupet-like partial fundoplication in early gastric cancer for preventing reflux esophagitis.

Authors:  Shinichi Sakuramoto; Keishi Yamashita; Shiro Kikuchi; Nobue Futawatari; Natsuya Katada; Hiromitsu Moriya; Kazuya Hirai; Masahiko Watanabe
Journal:  J Am Coll Surg       Date:  2009-06-18       Impact factor: 6.113

Review 9.  Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.

Authors:  Matthew F Buas; Thomas L Vaughan
Journal:  Semin Radiat Oncol       Date:  2013-01       Impact factor: 5.934

10.  Functional outcomes by reconstruction technique following laparoscopic proximal gastrectomy for gastric cancer: double tract versus jejunal interposition.

Authors:  Eiji Nomura; Sang-Woong Lee; Masaru Kawai; Masashi Yamazaki; Kazuhito Nabeshima; Kenji Nakamura; Kazuhisa Uchiyama
Journal:  World J Surg Oncol       Date:  2014-01-27       Impact factor: 2.754

View more
  10 in total

1.  The esophagogastric junctional adenocarcinoma an increasing disease.

Authors:  Monica Pastina; Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.

Authors:  Huihua Cao; Marie Ooi; Zhan Yu; Qing Wang; Zhong Li; Qicheng Lu; Yugang Wu
Journal:  J Gastrointest Surg       Date:  2018-10-17       Impact factor: 3.452

3.  Comparison of the prognosis of four different surgical strategies for proximal gastric cancer: a network meta-analysis.

Authors:  Ling Tan; Meng-Ni Ran; Zi-Lin Liu; Ling-Han Tang; Zhou Ma; Zhou He; Zhou Xu; Fang-Han Li; Jiang-Wei Xiao
Journal:  Langenbecks Arch Surg       Date:  2022-01-11       Impact factor: 3.445

4.  Comparison on the Efficacy of Double Tract Gastric Interposition Reconstruction Versus Jejunal Interposition Reconstruction After Proximal Gastrectomy.

Authors:  Chao Yue; Rui Peng; Wei Wei; Bin Zhou; Xu Wen; Rongmin Gu; Xuezhi Ming; Gang Li; Huanqiu Chen
Journal:  Med Sci Monit       Date:  2020-07-06

5.  Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study.

Authors:  Zhiguo Li; Jianhong Dong; Qingxing Huang; Wanhong Zhang; Kai Tao
Journal:  World J Surg Oncol       Date:  2019-12-06       Impact factor: 2.754

6.  Laparoscopic Double-Tract Esophago-Jejunostomy Reconstruction for Iatrogenic Esophageal Perforation After Endoscopic Pneumatic Dilatation for Achalasia: A Case Report.

Authors:  Saeed J Alshomimi; Mohammed S Foula; Jihad Q Alsafwani; Zahra H Alshammasi; Abdulrahim Ahmed Abdulmomen; Batool Salah Alzahir
Journal:  Am J Case Rep       Date:  2020-12-21

7.  Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction.

Authors:  Sijing Luo; Jiamin Xu; Wenjun Xiong; Jin Li; Lijie Luo; Yansheng Zheng; Haiping Zeng; Yangwen Liu; Licong Yang; Zhengqian Wu; Xiaobo Yang; Wei Wang
Journal:  Ann Transl Med       Date:  2021-10

8.  Clinical Comparison of Proximal Gastrectomy With Double-Tract Reconstruction Versus Total Gastrectomy With Roux-en-Y Anastomosis for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction.

Authors:  Xiaoming Ma; Mingzuo Zhao; Jian Wang; Haixing Pan; Jianqiang Wu; Chungen Xing
Journal:  J Gastric Cancer       Date:  2022-07       Impact factor: 3.197

9.  Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer.

Authors:  Sanchuan Lai; Tingting Su; Xingkang He; Zhenghua Lin; Shujie Chen
Journal:  Oncotarget       Date:  2017-12-20

10.  Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.

Authors:  Yinan Shi; Linjie Li; Huashi Xiao; Shanshan Guo; Guiping Wang; Kai Tao; Jianhong Dong; Liang Zong
Journal:  PLoS One       Date:  2018-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.